Infusystem Holdings, Inc insider trading
Every open-market purchase and sale by Infusystem Holdings, Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Infusystem Holdings, Inc’s insiders pay?
From March 1, 2010 to May 12, 2026, 32 insiders reported 97 open-market purchases and 40 sales not made under a pre-set plan in Infusystem Holdings, Inc. Twelve months after each purchase was reported, the shares were +9.0% against the S&P 500 on average (median −16.1%), over 21 purchases with a full year of prices; 43% beat the index. After sales, the shares moved −19.3% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 4, 2019 into $43,927 by November 2, 2026, +23.0% a year. It held shares 97% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $28,949 (+16.1% a year), and held throughout $28,565 (+15.8%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Lehman Gregg Owen | Director | 2 | — | — | 12 | −14.1% (12) | June 20, 2023 |
| Steen Eric K | President and CEO | 14 | — | — | 0 | — | December 19, 2016 |
| Sansone Christopher R. | Director | 9 | +155.8% (1) | 100% | 2 | −16.9% (2) | November 21, 2022 |
| Morris Ryan J. | Executive Chairman | 8 | — | — | 1 | — | May 19, 2017 |
| Steele Barry G | Executive VP and CFO | 8 | −13.7% (6) | 33% | 0 | — | May 12, 2026 |
| Blueline Capital Partners II, L.P. | Director | 6 | — | — | 1 | −28.9% (1) | December 9, 2020 |
| Malhotra R. Rimmy | Director | 0 | — | — | 7 | −63.0% (7) | September 8, 2023 |
| Blueline Partners, L.L.C. | Director | 5 | — | — | 1 | +74.1% (1) | March 31, 2020 |
| Meridian Tsv II, LP | Director | 5 | — | — | 1 | +39.3% (1) | June 29, 2020 |
| Shuda Scott | Director | 5 | — | — | 1 | +1.4% (1) | August 22, 2025 |
| Tsv Investment Partners, LLC | Director | 5 | — | — | 1 | −26.3% (1) | September 30, 2020 |
| Gendron Paul Andrew | Director | 5 | −4.3% (4) | 25% | 0 | — | May 12, 2026 |
| Meridian Ohc Partners, LP | Director | 4 | — | — | 1 | +51.0% (1) | June 30, 2020 |
| Lachance Carrie | President and CEO | 4 | −6.5% (3) | 33% | 0 | — | May 12, 2026 |
| Ruiz Thomas Mark | Chief Commercial Officer | 0 | — | — | 4 | −5.0% (4) | September 6, 2022 |
| Dilorio Richard | Chief Executive Officer | 2 | −25.9% (1) | 0% | 1 | −33.3% (1) | March 23, 2023 |
| Dreyer David C | Director | 0 | — | — | 3 | — | June 26, 2018 |
| Eichenbaum Kenneth D. | Director | 2 | +35.0% (2) | 100% | 0 | — | May 28, 2025 |
| Foster Jonathan P. | Chief Financial Officer | 2 | — | — | 0 | — | May 18, 2015 |
| Kleinheinz John B | 10% owner | 1 | — | — | 1 | — | March 1, 2010 |
| Sheehan Jeannine | Chief Administrative Officer | 0 | — | — | 2 | −34.3% (2) | January 4, 2022 |
| Armstrong Terry L. | Director | 1 | — | — | 0 | — | August 22, 2018 |
| Awm Investment Company, Inc. | 10% owner | 1 | — | — | 0 | — | August 13, 2019 |
| Boyd Ralph F | Director | 1 | −34.5% (1) | 0% | 0 | — | May 23, 2024 |
| Downs Christopher | CFO (interim) | 1 | — | — | 0 | — | August 16, 2017 |
| Great Point Partners LLC | 10% owner | 0 | — | — | 1 | — | February 10, 2011 |
| Hundzinski Ronald T | Director | 1 | +30.3% (1) | 100% | 0 | — | May 20, 2025 |
| Huss Beverly A | Director | 1 | −34.5% (1) | 0% | 0 | — | May 23, 2024 |
| Meridian Ohc LLC | Director | 1 | +147.9% (1) | 100% | 0 | — | September 6, 2019 |
| Meson Capital Partners LP | Executive Chairman | 1 | — | — | 0 | — | May 11, 2012 |
| Montgomery Darrell B | Director | 1 | — | — | 0 | — | August 16, 2017 |
| Whitters Joseph E | Director | 1 | — | — | 0 | — | May 11, 2012 |
When several insiders traded Infusystem Holdings, Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Infusystem Holdings, Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 4 buying crowds with six months of prices, it averaged +18.5% against the index. After 4 selling crowds, +17.5%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| May 29, 2026 | 3 buying | +30.8% | not yet | not yet |
| May 30, 2025 | 4 buying | +76.7% | +43.9% | +23.3% |
| May 31, 2024 | 4 buying | −14.1% | +9.7% | −29.0% |
| March 31, 2023 | 3 buying | +14.8% | +19.5% | −22.9% |
| November 30, 2022 | 3 selling | +12.3% | +0.4% | +3.3% |
| December 31, 2021 | 3 selling | −37.8% | −25.1% | −30.4% |
| October 30, 2020 | 4 selling | +30.7% | +49.0% | −10.0% |
| June 30, 2020 | 3 selling | +11.1% | +45.8% | +39.3% |
| March 29, 2019 | 3 buying | −18.4% | +0.8% | +74.7% |